NCT06371651

Brief Summary

The main aim of this randomized controlled trial is to evaluate cerebral blood oxygenation after 7-day administration of a creatine-guanidinoacetic acid (GAA) mixture in healthy adults before, during, and after a series of cognitive tests.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2024

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 14, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 17, 2024

Completed
Last Updated

May 9, 2024

Status Verified

May 1, 2024

Enrollment Period

1 month

First QC Date

April 14, 2024

Last Update Submit

May 6, 2024

Conditions

Keywords

creatineguanidinoacetic acidoxygen saturationbrain

Outcome Measures

Primary Outcomes (1)

  • Brain oxygen saturation

    Percentage of oxygen saturation in prefrontal brain

    Change from baseline brain oxygen saturation at 2 weeks

Secondary Outcomes (1)

  • Hemoglobin index

    Change from baseline hemoglobin index at 2 weeks

Study Arms (2)

Supplement

EXPERIMENTAL

One sachet of supplement before breakfast and dinner

Dietary Supplement: Supplement

Placebo

PLACEBO COMPARATOR

One sachet of inert compound before breakfast and dinner

Dietary Supplement: Placebo

Interventions

SupplementDIETARY_SUPPLEMENT

Dietary supplement containing creatine and guanidinoacetic acid

Supplement
PlaceboDIETARY_SUPPLEMENT

Inert substance

Placebo

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-30 years
  • Absence of metabolic disorders or other health complications
  • Provision of signed informed consent

You may not qualify if:

  • History of dietary supplement use within the preceding 4 weeks
  • Lack of consent to randomization
  • Concurrent participation in other studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Applied Bioenergetics Lab at Faculty of Sport and PE

Novi Sad, Vojvodina, 21000, Serbia

Location

Related Publications (3)

  • Watanabe A, Kato N, Kato T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res. 2002 Apr;42(4):279-85. doi: 10.1016/s0168-0102(02)00007-x.

    PMID: 11985880BACKGROUND
  • Hammett ST, Wall MB, Edwards TC, Smith AT. Dietary supplementation of creatine monohydrate reduces the human fMRI BOLD signal. Neurosci Lett. 2010 Aug 2;479(3):201-5. doi: 10.1016/j.neulet.2010.05.054. Epub 2010 May 24.

    PMID: 20570601BACKGROUND
  • Zanini D, Todorovic N, Ostojic SM. Creatine with guanidinoacetic acid improves prefrontal brain oxygenation before, during, and after a cognitive task: A randomized controlled pilot trial. Nutr Health. 2025 Jun;31(2):363-368. doi: 10.1177/02601060241300236. Epub 2024 Nov 21.

Related Links

MeSH Terms

Conditions

Hypoxia

Interventions

Dietary Supplements

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Sergej Ostojic, MD, PhD

    University of Novi Sad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 14, 2024

First Posted

April 17, 2024

Study Start

March 1, 2024

Primary Completion

April 10, 2024

Study Completion

April 12, 2024

Last Updated

May 9, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Data obtained through this study may be provided to qualified researchers with academic interest in nutritional neuroscience. Data will be coded, with no PHI included. Approval of the request and execution of all applicable agreements are prerequisites to the sharing of data with the requesting party.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Data requests can be submitted starting 6 months after article publication and the data will be made accessible for up to 12 months. Extensions will be considered on a case-by-case basis.
Access Criteria
Only qualified researchers with academic interest in in nutritional neuroscience

Locations